2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (


Journal

Bioanalysis
ISSN: 1757-6199
Titre abrégé: Bioanalysis
Pays: England
ID NLM: 101512484

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 14 12 2019
medline: 28 4 2020
entrez: 14 12 2019
Statut: ppublish

Résumé

The 2019 13

Identifiants

pubmed: 31833782
doi: 10.4155/bio-2019-0270
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2099-2132

Auteurs

Brian Booth (B)

US FDA, Silver Spring, MD, USA.

Lauren Stevenson (L)

Biogen, Cambridge, MA, USA.

Renuka Pillutla (R)

Bristol-Myers Squibb, Princeton, NJ, USA.

Michael Buonarati (M)

Intertek, San Diego, CA, USA.

Chris Beaver (C)

Syneos Health, Princeton, NJ, USA.

Daniela Fraier (D)

F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Fabio Garofolo (F)

Angelini Pharma, Rome, Italy.

Sam Haidar (S)

US FDA, Silver Spring, MD, USA.

Rafiq Islam (R)

Celerion, Lincoln, NE, USA.

Christopher James (C)

Amgen Research, Thousand Oaks, CA, USA.

John Kadavil (J)

US FDA, Silver Spring, MD, USA.

Olga Kavetska (O)

Pfizer, Groton, CT, USA.

Fumin Li (F)

PPD, Middleton, WI, USA.

Christina Satterwhite (C)

Charles River, Reno, NV, USA.

Natasha Savoie (N)

CFABS, Montreal, QC, Canada.

Sriram Subramaniam (S)

US FDA, Silver Spring, MD, USA.

Nilufer Tampal (N)

US FDA, Silver Spring, MD, USA.

Theingi Thway (T)

US FDA, Silver Spring, MD, USA.

Eric Woolf (E)

Merck Research Labs, West Point, PA, USA.

Olivier Le Blaye (OL)

France ANSM, Saint Denis, France.

Matthew Andisik (M)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Chad Briscoe (C)

PRA Health Sciences, Lenexa, KS, USA.

Stephanie Cape (S)

Covance, Madison, WI, USA.

Arindam Dasgupta (A)

US FDA, Silver Spring, MD, USA.

Sally Fischer (S)

Genentech, South San Francisco, CA, USA.

Sam Haidar (S)

US FDA, Silver Spring, MD, USA.

Roger Hayes (R)

ICON, Whitesboro, NY, USA.

John Kamerud (J)

Pfizer, Andover, MA, USA.

Gustavo Mendes Lima Santos (GM)

Brazil ANVISA, Brasilia, Brazil.

Corey Nehls (C)

PPD, Richmond, VA, USA.

Catherine Soo (C)

Health Canada, Ottawa, ON, Canada.

Stephen Vinter (S)

UK MHRA, London, UK.

Emma Whale (E)

UK MHRA, London, UK.

Keyang Xu (K)

Genentech, South San Francisco, CA, USA.

Seongeun Julia Cho (SJ)

US FDA, Silver Spring, MD, USA.

Anna Edmison (A)

Health Canada, Ottawa, ON, Canada.

Sean Kassim (S)

US FDA, Silver Spring, MD, USA.

Thais Correa Rocha (TC)

Brazil ANVISA, Brasilia, Brazil.

Jan Welink (J)

EMA, London, UK.

Shashi Amur (S)

US FDA, Silver Spring, MD, USA.

Abbas Bandukwala (A)

US FDA, Silver Spring, MD, USA.

Elana Cherry (E)

Health Canada, Ottawa, ON, Canada.

Shirley Hopper (S)

UK MHRA-NIBSC, London, UK.

Akiko Ishii-Watabe (A)

Japan MHLW-NIHS, Tokyo, Japan.

Susan Kirshner (S)

US FDA, Silver Spring, MD, USA.

Kevin Maher (K)

US FDA, Silver Spring, MD, USA.

Joao Pedras-Vasconcelos (J)

US FDA, Silver Spring, MD, USA.

Yoshiro Saito (Y)

Japan MHLW-NIHS, Tokyo, Japan.

Therese Solstad Saunders (TS)

Norwegian Medicines Agency (NoMA), Oslo, Norway.

Venke Skibeli (V)

Norwegian Medicines Agency (NoMA), Oslo, Norway.

Daniela Verthelyi (D)

US FDA, Silver Spring, MD, USA.

Yow-Ming Wang (YM)

US FDA, Silver Spring, MD, USA.

Haoheng Yan (H)

US FDA, Silver Spring, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH